© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

SRI

Top section

Top section

International issuers crowd into Swiss francs

Foreign corporate issuance running at record high
AI issuance is becoming increasingly concentrated — beware

ING banker moves to Asian Development Bank

Recently departed banker to resurface in Asia

Csquare's IPO to chip away at $3bn of ABS debt

IPO documents reveal data center portfolio purchase
AI issuance is becoming increasingly concentrated — beware
Sub-sections
  • Yves Mersch, one of the ECB governing council’s staunchest hawks, has a new argument for why the central bank must abridge its purchase programmes: by keeping down the borrowing costs of the eurozone periphery, the ECB is helping countries to “circumvent EU loans”, which he thinks should not be allowed to happen.
  • Gland Pharma, a subsidiary of Chinese conglomerate Shanghai Fosun Pharmaceutical Group, has started bookbuilding for its Indian IPO, set to be the largest pharmaceutical listing in the country.
  • India’s Emcure Pharmaceuticals has returned to the loan market after four years, seeking a small amount of $34m.